JuliaOmix LAB
JuliaOmix LAB is a web platform for genomic data analysis and interpretation, aimed at medical geneticists, laboratory technicians and clinical researchers. It offers customisable variant filters, advanced visualisation and integration with sequencing instruments. No public pricing is published.
What is JuliaOmix LAB?
JuliaOmix LAB is the genomic analysis module of the JuliaOmix suite published by the Italian company GenomeUp S.r.l. The suite is divided into four modules with distinct scopes: MED for patients and clinical records, TRK for sample traceability, CLD for GDPR-compliant cloud archiving, and LAB, presented as the complete solution for geneticists and dedicated to the analysis and interpretation of genomic data. Only LAB is covered here; patient files and sample tracking belong to the other modules.
The product page states a simple promise: to make genomic analysis accessible, fast and precise through an interactive, intuitive platform. Four arguments carry it - an intuitive analysis interface, customisable filters that let a laboratory target and prioritise specific variants, advanced visualisation in a user-friendly grid meant to support genotype-phenotype correlation, and seamless integration with a range of sequencing instruments and other platforms. The publisher says variants can be explored at several degrees of resolution, from fine detail up to large-scale genomic anomalies.
Four professional profiles are named: IT and data manager, laboratory technician, medical geneticist and clinical researcher. Onboarding is described in three steps - account creation with team permissions and multi-factor authentication, drag-and-drop loading of genomic files in standard or custom formats, then configuration of filters and reusable analysis templates.
The working application is a separate web app served at lab.juliaomix.com; the older platform.genomeup.com address now carries only a redirect notice. Its route table is considerably wider than the marketing page suggests: batch FASTQ, somatic, RNA-seq, multi-VCF and trio analysis, metagenomics, NIPT, digital and microscope cytogenetics, CNV and coverage, FastQC and fastP quality control, VEP annotation, a genome viewer and report generation. Its interface is in English, while the commercial site is entirely in Italian.
Two things deserve to be kept in proportion. The headline figures - more than 70,000 patients, more than 15,000 sequencing runs and 22 active installations in Italy and Europe - are claimed for GenomeUp and its suite, not for LAB on its own. And while GenomeUp publishes ISO 9001 and ISO 13485 certificates and declares ISO 27001, 27017, 27018, 20000 and 22301, it states that these attest company management systems rather than specific products. No price is published: entry runs through the contact form.
What it does
- Analyse sequencing output across the workflows the application exposes: batch FASTQ, multi-VCF, trio, somatic, RNA-seq, metagenomics, NIPT and cytogenetics
- Import genomic files by drag and drop, in standard or custom formats
- Set filters and criteria to identify and prioritise the variants of interest
- Explore genomic events in an interactive grid and in a genome viewer
- Generate analysis reports from completed analyses
- Manage team accounts, roles and permissions, with multi-factor authentication
When to use JuliaOmix LAB / When not to
A quick filter to help you decide if JuliaOmix LAB is the right fit.
When to use JuliaOmix LAB
- Medical geneticists who want to analyse and interpret genomic data themselves, without having to rely on an IT or bioinformatics specialist - the profile the product page names first.
- Clinical genetics laboratories and research institutes that already run NGS sequencers and are looking for an interpretation layer to sit on top of them.
- Laboratory technicians who need drag-and-drop import of standard or custom genomic file formats and reusable analysis templates for recurring work.
- Bioinformaticians and clinical researchers who need variant exploration at several degrees of resolution, from fine detail up to large-scale genomic anomalies.
- IT and data managers responsible for team accounts, role-based permissions and multi-factor authentication inside a laboratory.
When not to use JuliaOmix LAB
- Individuals looking for a consumer DNA or ancestry test: this is professional laboratory software, with no online purchase, no self-service sign-up and no announced trial.
- Teams that have to budget from a published price list, since no price, plan or tariff for the product appears anywhere on the publisher's site.
- Buyers who require a CE-marked or IVDR-classified in vitro diagnostic device: no marking and no device class is claimed for JuliaOmix LAB, and the publisher states that its listed certifications attest management systems and do not certify specific products or services.
- Developers who want to embed genomic analysis in their own stack: no public API documentation is published and there is no mobile application.
- Buyers who expect to evaluate a vendor from published documents alone: the commercial documentation is in Italian only and the JuliaOmix brand site is currently down.
How to use JuliaOmix LAB
A typical end-to-end flow, from setup to results.
- Start with the contact form on the publisher's site - surname, first name, email, telephone, organisation, professional role and your request - since there is no open sign-up
- Agree access with GenomeUp: a commercial conversation is the only documented way in
- Create your personal account on the application at lab.juliaomix.com and set your team's permissions
- Enable multi-factor authentication, which the publisher presents as part of that first step
- Load genomic files by drag and drop, in standard or custom formats, from your sequencer output
- Or import from Google Drive or Google Cloud Storage, for which the application requests the matching OAuth scopes
- Configure the filters and criteria that define which variants you want prioritised
- Save recurring analysis templates so that repeat workflows start from a known configuration
- Explore the results in the interactive grid and in the genome viewer, at the resolution you need
- Generate the analysis report once the analysis is complete
Pros & Cons
Pros
- Broad and concrete functional coverage for a genetics laboratory, from quality control through annotation and variant exploration to report generation
- Explicitly designed so that a geneticist can work without a dedicated bioinformatics specialist
- Publisher certified to ISO 9001 and ISO 13485, with the certificates published as downloadable PDFs, and declaring ISO 27001, 27017, 27018, 20000 and 22301 as well
- Multi-factor authentication is more than a claim: the application exposes a two-factor login route
- Member of Confindustria Dispositivi Medici, with annual transfers of value published, an organisational model under Legislative Decree 231 and a code of ethics online
- Substantial and dated public funding, verifiable on the publisher's own transparency page
- A claimed installed base of 22 active installations in Italy and Europe - stated at suite level rather than for LAB alone, but a sign of real deployments
Cons
- No public price, no plan and no announced trial: the budget cannot be estimated without a sales conversation
- No contractual terms for the platform at all - the only Terms and Conditions page on the site governs a different product, sold on a domain that no longer resolves
- The privacy policy is a generated template covering the marketing website rather than the platform, with no retention period, no data processing agreement, no sub-processor list and no declared hosting country
- The JuliaOmix brand site is down, returning a WordPress database error, so the product documentation it would carry is unavailable
- Site upkeep is poor: the header logo referenced by the homepage returns 404, and the footer carries injected spam links to betting and casino sites, which points to a compromised WordPress installation
- Commercial documentation exists in Italian only, while the application interface is in English
- No public API documentation, no named team - the Conosci il Nostro Team page leads nowhere - and no working social profile, the icons carrying no URL and being hidden at every breakpoint
Pricing & Plans
No price for JuliaOmix LAB is published. The publisher operates no pricing page, and no product tariff appears anywhere on the site, in any locale. Neither a free plan nor a free trial is announced, and neither is ruled out. The observable model is contact-sales: a prospective user requests access and a quotation through the contact form.
Data, GDPR & hosting
A consolidated view of how JuliaOmix LAB handles your data.
GDPR overview
GDPR implementation is partly documented and partly asserted. The homepage claims that sensitive data are protected by encryption and multi-factor authentication in full compliance with GDPR, but that sentence describes the GenomeUp platform in general. The privacy policy, effective 1 April 2025, sets out data subject rights: access, rectification, erasure, a copy of the data, restriction, objection, portability, withdrawal of consent and complaint to a supervisory authority. Rights, and objection to direct marketing and marketing profiling, are exercised at info@genomeup.com, where a Grievance Officer also answers; no DPO is named. The publisher is established in Italy, so no Article 27 representative is expected. The gaps are real: no data processing agreement, no sub-processor list and no stated retention period, and the policy may be amended without notice.
Who owns the data?
No published document states who owns the customer or genomic data handled by JuliaOmix LAB. The only privacy policy on the site, effective 1 April 2025, is a CookieYes-generated template that expressly covers use of the www.genomeup.com website rather than the platform, and it contains no data-ownership clause. It names GenomeUp srl, Viale Volga c/o Fiera del Levante Pad. 129, Bari 70132, Italy as the controller for that website. No customer contract, licence agreement or data processing agreement for the platform is published, and the terms and conditions hosted on the site govern an unrelated consumer DNA kit. Ownership and permitted uses therefore have to be settled contractually with the publisher before any data is loaded.
Reuse rights
Within the only scope it actually covers, the marketing website, the privacy policy lists the purposes as marketing and promotional activity, testimonials, customer feedback collection, support and targeted advertising, and states that any other use requires prior consent. First-party and third-party cookies are described in a separate cookie policy carrying the same 1 April 2025 effective date. Nothing published says whether customer or genomic data may be reused to train models - the publisher is silent in both directions. For the platform itself, GenomeUp advertises encryption and multi-factor authentication, and the application does expose a two-factor login route, but it publishes no reuse, licensing or output-ownership terms. An end user therefore has no documented permission to reuse platform data beyond what a signed contract grants.
Data retention & training
Hosting summary
GenomeUp declares no hosting country and no hosting region for customer data. The LAB product page mentions only an advanced cloud infrastructure, with no location, no provider and no jurisdiction attached to it. The GDPR-compliant cloud archiving described in the suite belongs to the CLD module, not to LAB. No data processing agreement and no sub-processor list is published, so nothing documents onward transfers or the parties involved. Two things can be observed technically from outside, and they are observations rather than commitments given by the publisher: the marketing website resolves to an Aruba S.p.A. address in Italy, and the application at lab.juliaomix.com is served through CloudFront while its front-end bundle calls Google Cloud Storage. None of that tells you where genomic data submitted to the platform is actually stored, under which contract, or in which jurisdiction. For a laboratory handling health data, that is the first question to put to the vendor in writing.
Things to keep in mind
Risks and trade-offs to weigh before adopting JuliaOmix LAB.
- The Terms and Conditions page on the site does not govern JuliaOmix LAB: it covers a consumer DNA test kit sold on dna.awexome.it, a domain that no longer resolves. No contractual document for the platform is published at all, so nothing public settles data ownership - and the same page states a registered office in Rome, Via Nemorense 91, contradicting the Bari address in the site footer.
- The certifications published cover the company's management systems and not the product; the site says so itself. ISO 13485 is a quality management standard for medical devices, not a certification of this software.
- No CE marking and no medical device class is claimed for JuliaOmix LAB. Any clinical or diagnostic use has to be qualified with the publisher and against your own regulatory duties before it is relied on.
- The headline figures - over 70,000 patients, over 15,000 sequencing runs, 22 active installations - are advertised for GenomeUp and its suite, not for JuliaOmix LAB on its own. Do not read them as adoption of this module.
- The site footer carries injected spam links to betting and casino sites, plus a third-party insertion in the middle of a sentence: the WordPress installation appears compromised. Treat outbound links from the site with caution and report it to the publisher.
- Operational upkeep is uneven - the header logo returns 404 and the juliaomix.com brand site returns a database error - so the documentation a buyer needs may simply be unavailable at the moment it is needed.
- Filters and saved templates shape what a reviewer ever sees: a rule that hides a variant hides it every time it runs. With no published documentation of the interpretation logic, human review and independent confirmation have to stay in the loop rather than being replaced by the tool's ranking.
Setup & Integrations
Technical difficulty
Low for the end user once access has been granted. The publisher describes a three-step start - account creation with team permissions and multi-factor authentication, drag-and-drop loading of genomic files, then filter and template configuration - and explicitly targets geneticists working without bioinformatics support. Dedicated support is advertised and the application points to an Atlassian service desk. The real friction sits upstream: there is no self-service sign-up, so onboarding begins with a sales cycle, and no public technical documentation, installation guide or API reference exists to prepare the work in advance.
Deployment
Integrations
Supported languages
Behind JuliaOmix LAB
Fundraising
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
What kind of genomic data can JuliaOmix LAB analyse?
Can the filters be customised?
How are results visualised?
How much does JuliaOmix LAB cost?
Is there a free trial or a free plan?
Is there an API?
Where does the application actually run?
What certifications does the publisher hold?
Is JuliaOmix LAB a CE-marked medical device?
Who publishes the tool, and in what language does it work?
Should you pick JuliaOmix LAB?
JuliaOmix LAB is a narrow but serious vertical tool. It addresses genetics laboratories and research institutes, chiefly in Italy, and it does so with a functional range that goes well beyond the four selling points on its product page: the application covers quality control, annotation, variant exploration at several resolutions, a genome viewer and report generation, with workflows for trio, somatic, RNA-seq, metagenomics, NIPT and cytogenetics.
At company level, the compliance base is real and checkable. GenomeUp publishes ISO 9001 and ISO 13485 certificates, declares five further ISO standards, belongs to Confindustria Dispositivi Medici with published transfers of value, maintains an organisational model under Legislative Decree 231 with a code of ethics, and documents substantial dated public funding on its transparency page.
Product transparency is the weak side, and the gap is wide. There is no price, no plan and no announced trial. There are no contractual terms for the platform at all: the only terms and conditions page on the site governs a consumer DNA kit sold on a domain that no longer resolves, and it even states a different registered office. The privacy policy is a template covering the marketing website, with no retention period, no data processing agreement, no sub-processor list and no declared hosting country. Nothing published claims a CE marking or a medical device class for the product, and the publisher itself says its certifications cover management systems rather than specific products - a point a clinical buyer has to settle before purchase.
Site upkeep reinforces the impression: the header logo returns 404, the JuliaOmix brand site returns a database error, and the footer carries injected spam links. Evaluating this tool therefore means talking to the vendor, because almost nothing that matters commercially can be assessed from what is published.
- Choosing a selection results in a full page refresh.
- Opens in a new window.